09/27/2018

IVI’s 18th Vaccinology Course gathers 120 international participants from 19 countries in Seoul September 3-7

Annual Course to update on the recent development in vaccinology, including basics of immunology, epidemiology, vaccine design and development Featured experts include: Stanley Plotkin (University of Pennsylvania), Dr. Barney Graham (US NIH), Dr. Randy Schoepp (USAMRID), Dr. Andy Pollard (University of Oxford), and Dr. Eric […]
10/01/2018

IVI accelerates development of MERS vaccine

– Institute jointly conducts phase 1/2a clinical trial of GeneOne Life Science’s GLS-5300 DNA MERS vaccine – IVI in search of additional promising candidate vaccines among developers worldwide, with support from Samsung Life Public Welfare Foundation   The International Vaccine Institute (IVI) said on September […]
10/05/2018

Let’s build a common defense against epidemics

This recent Op-Ed in the Financial News, a leading business daily in Korea, by IVI’s Director General, Dr. Jerome Kim, details the essential nature of pre-emptive vaccine development and the need for global collaboration to prevent epidemics involving certain emerging pathogens. He urges Korea to […]
10/08/2018

Welcome to our new website!

The International Vaccine Institute (IVI) is pleased to announce the launch of our new website as part of our efforts to better connect and communicate with you. We have given our site a fresher, more contemporary look and feel. We hope you find it easier […]